Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares traded down 1.6% on Wednesday . The company traded as low as $1.18 and last traded at $1.21. Approximately 1,416,014 shares traded hands during mid-day trading, an increase of 2,010% from the average session volume of 67,097 shares. The stock had previously closed at $1.23.
Cardiol Therapeutics Stock Performance
The firm’s 50-day simple moving average is $1.14 and its 200 day simple moving average is $1.13.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Featured Articles
- Five stocks we like better than Cardiol Therapeutics
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
